Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs NVS✓SelectedUSD · NVSGSK vs NVS performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs NVS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+481.2%
NVS return
+1,273.7%
Excess return
-792.5%
Maximum drawdown
-51.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioNVSExcessAlpha
1D+0.5%+0.2%+0.4%+0.4%
7D+1.1%-1.3%+2.4%+1.9%
30D+6.3%+9.3%-2.9%+1.0%
3M+1.8%+5.8%-4.0%-2.3%
6M+1.7%+7.2%-5.5%-3.2%
YTD+6.5%+20.0%-13.4%-4.8%
1Y+9.5%+25.4%-15.9%-4.7%
3Y+65.3%+89.2%-23.9%+13.4%
5Y+43.7%+134.6%-90.9%-13.3%
10Y+104.1%+251.4%-147.2%-3.0%
All+481.2%+1,273.7%-792.5%+30.2%

Cumulative growth

Daily Returns

Daily percentage return beside NVS.

Daily Out/Under-Performance

Portfolio return minus NVS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded NVS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling